510(k) device
Accu-Chek Guide Solo diabetes manager blood glucose monitoring system
Roche Diabetes Care GmbH · System, Test, Blood Glucose, Over The Counter (NBW, Class II) · First FDA decision Aug 31, 2016, newest Aug 10, 2023Diabetes
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
3
510(k) pathway
Device trials
58
Naming "Accu-Chek"
MAUDE reports
54,141
Brand "Accu-Chek", since 2015
PubMed studies
295
Mentioning "Accu-Chek"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Accu-Chek Guide Solo diabetes manager blood glucose monitoring system
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology, with pictures of the device
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 3 of 3 decisions filed under this name.
K213131 · Decided Aug 10, 2023 · 682 days after receipt
Device type: System, Test, Blood Glucose, Over The Counter (NBW) · Laboratory Medicine & Pathology
2 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Blood Glucose TestingNational determinationOn the books190.20Updated Oct 1, 2026
- Lipid and Blood Glucose Testing (Modification of Code List to Implement Screening Benefit Added by Medicare Modernization Act (MMA)Coding analysisReview closedCAG-00266NUpdated Sep 14, 2026
- Home Blood Glucose MonitorsNational analysisReview closedCAG-00161NUpdated Sep 14, 2026
- Blood Glucose Testing (Revision of ICD-9-CM Codes for Osteomyelitis)Coding analysisReview closedCAG-00183NUpdated Sep 14, 2026
- Home Blood Glucose MonitorsNational determinationOn the books40.2Updated Dec 2, 2024
- Closed-Loop Blood Glucose Control Device (CBGCD)National determinationOn the books40.3Updated Apr 17, 2020
Clinical trials
Device studies on ClinicalTrials.gov that name "Accu-Chek", any status and sponsor, newest update first.
- Clinical Study to Evaluate the Impact of the Accu-Chek SmartGuide CGM Solution on the Mean Change in Time in Range Compared With Self-Monitoring of Blood Glucose in Participants With Type 1 and Type 2 Diabetes MellitusPivotal-lookingActive, not recruiting
Hoffmann-La RocheNot on our public-company list
NCT06704672 · 270 participants (planned) · Start Apr 14, 2025 · Primary completion Jan 15, 2027
Device: Accu-Chek SmartGuide CGM Solution; Accu-Chek SmartGuide Sensor and Blinded Apps and 1 more · For: Type 1 Diabetes Mellitus; Type 2 Diabetes Mellitus
Sites: Gdansk, Poland; Krakow, Poland; Kraśnik, Poland · 19 sites in all
57 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Accu-Chek", and for the whole product code for context.
This brand
54,141 reports: 51,098 malfunction, 3,020 injury, 12 death
Whole product code NBW
258,305 reports: 243,487 malfunction, 14,268 injury, 39 death
Newest reports for this brand
- ACCU-CHEK ® FASTCLIXMalfunction
3011393376-2026-00677 · Received Oct 29, 2026 · Event dated Oct 21, 2026
Device type: Multiple Use Blood Lancet For Single Patient Use Only (QRL)
Device problem as coded: Retraction Problem
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
4 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-2174-2024 · Started May 13, 2024 · Posted by FDA Jun 21, 2024
Reason given: The reason for recall is the meters may show an incorrect measurement unit (mmol/L rather than mg/dL) and may result in the wrong unit of measure. Which may subsequently cause an error in interpreting a result as approximately 18 times lower that the actual blood glucose. Potential immediate health consequences of the...
Cause as FDA categorized it: Reprocessing Controls · Device type: System, Test, Blood Glucose, Over The Counter (NBW)
1 more recall records with a free account
Published research
The most relevant PubMed records for "Accu-Chek"[tiab]. The summary above synthesizes these.
- Patch Pumps: Periodic Insulin Delivery Patterns.
Eichenlaub M, Ziegler R, Heinemann L, et al. · J Diabetes Sci Technol · 2023
- Analytical validation of a portable human Accu-Chek glucometer in honeybee hemolymph.
Cournoyer A, Deschamps A, Bau-Gaudreault L, et al. · J Vet Diagn Invest · 2022
- Enhancing the Capabilities of Continuous Glucose Monitoring With a Predictive App.
Herrero P, Andorrà M, Babion N, et al. · J Diabetes Sci Technol · 2024Research Support, Non-U.S. Gov't
- Bedside cerebrospinal fluid glucose analysis.
Slovis CM, Negus RA, Amerson SM, et al. · Ann Emerg Med · 1989
- Predicting Glucose Values: A New Era for Continuous Glucose Monitoring.
Kulzer B, Heinemann L · J Diabetes Sci Technol · 2024Editorial
- Reducing Treatment Errors Through Point-of-Care Glucometer Configuration.
Estock JL, Pham IT, Curinga HK, et al. · Jt Comm J Qual Patient Saf · 2018Multicenter Study, Randomized Controlled Trial
- Clinical Usage and Potential Benefits of a Continuous Glucose Monitoring Predict App.
Glatzer T, Ehrmann D, Gehr B, et al. · J Diabetes Sci Technol · 2024Research Support, Non-U.S. Gov't
- Large-scale performance evaluation of Accu-Chek inform II point-of-care glucose meters.
Jeong TD, Cho EJ, Ko DH, et al. · Scand J Clin Lab Invest · 2016
- Comparison of Accu Chek Inform II point-of-care test blood glucose meter with Hexokinase Plasma method for a diabetes mellitus population during surgery under general anesthesia.
Lascaris B, Freling HG, Edens MA, et al. · J Clin Monit Comput · 2022
- [Erratum in "Point-of-Care Blood Glucose Testing: Post-Market Performance Assessment of the Accu-Chek Inform II Hospital-Use Glucose Meter" (DOI: 10.26442/00403660.2023.12.202522)].
Petryaykina EE, Mayanskiy NA, Demina ES, et al. · Ter Arkh · 2024English Abstract
- Glucose measurements with accu check inform II versus hexokinase plasma method during surgery under general anesthesia, an observational cohort study.
Kaufmann T, Slingerland RJ, Edens MA, et al. · J Clin Monit Comput · 2024Observational Study
- Optimizing mHealth Technologies in Real-World Clinical Practices.
Mora P, Biggs WC, Parkin CG · Clin Diabetes · 2019
Other devices of this type
Also filed under product code NBW.
- RIGHTEST Blood Glucose Monitoring System Max TelBionime Corporation · 510(k) 2024
- On Call Express II Blood Glucose Monitoring SystemACON Laboratories, Inc. · 510(k) 2019
- FreeStyle Precision Neo Blood Glucose Test StripsAbbott Diabetes Care, Inc. · 510(k) 2017
- POGO Automatic Blood Glucose Monitoring SystemIntuity Medical, Inc. · 510(k) 2018
- iHealth Align Gluco-Monitoring System (BG1)Andon Health Co, Ltd. · 510(k) 2017
- True Metrix Self-Monitoring Blood Glucose SystemNipro Diagnostics, Inc. · 510(k) 2014
- Clever Chek Blood Glucose Monitoring SystemTaidoc Technology Corporation · 510(k) 2009
- Modification to Accu-Chek Active SystemRoche Diagnostics Corp. · 510(k) 2002
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.